These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 17938571

  • 1. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Jung YJ, Kim YJ, Kim LH, Lee SO, Park BL, Shin HD, Lee HS.
    Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS.
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [Abstract] [Full Text] [Related]

  • 4. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim YJ, Kim HY, Kim JS, Lee JH, Yoon JH, Kim CY, Park BL, Cheong HS, Bae JS, Kim S, Shin HD, Lee HS.
    J Viral Hepat; 2010 Jul; 17(7):518-26. PubMed ID: 19780938
    [Abstract] [Full Text] [Related]

  • 5. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
    Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH.
    Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI, Lu PJ, Wang EM, Ger LP, Lo GH, Tsay FW, Chen TA, Yang HB, Chen HC, Lin WS, Lai KH.
    Anticancer Res; 2008 Jun; 28(1A):97-103. PubMed ID: 18383830
    [Abstract] [Full Text] [Related]

  • 7. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N.
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [Abstract] [Full Text] [Related]

  • 8. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M, Kotsafti A, Cardin R, Farinati F.
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [Abstract] [Full Text] [Related]

  • 9. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F, Xia Z, Qu Y, Tang Y, Cao D, Sun P, Christiani DC.
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.
    Clin Cancer Res; 2009 Mar 01; 15(5):1794-800. PubMed ID: 19240174
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM, Wang N, Chen ZF, Duan YN, Sun DL, Li Y.
    J Gastroenterol Hepatol; 2010 Mar 01; 25(3):555-61. PubMed ID: 20074157
    [Abstract] [Full Text] [Related]

  • 13. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
    Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G.
    J Viral Hepat; 2005 Nov 01; 12(6):568-73. PubMed ID: 16255757
    [Abstract] [Full Text] [Related]

  • 14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep 01; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG, Barlas IO, Durakbasi-Dursun G, Ural O, Erdal E, Yildirim MS.
    Int J Immunogenet; 2013 Dec 01; 40(6):482-7. PubMed ID: 23560484
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D, Zhang X, Guo Y, Lin D.
    Carcinogenesis; 2007 May 01; 28(5):1067-73. PubMed ID: 17183065
    [Abstract] [Full Text] [Related]

  • 18. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
    Migita K, Sawakami-Kobayashi K, Maeda Y, Nakao K, Kondoh S, Sugiura M, Kawasumi R, Segawa O, Tajima H, Machida M, Nakamura M, Yano K, Abiru S, Kawasaki E, Yatsuhashi H, Eguchi K, Ishibashi H.
    Transl Res; 2009 Feb 01; 153(2):91-6. PubMed ID: 19138654
    [Abstract] [Full Text] [Related]

  • 20. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection.
    Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH.
    Biochem Genet; 2006 Jun 01; 44(5-6):246-55. PubMed ID: 16944293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.